Vimarsana
Biggest News Aggregation in the World

Page 2 - Pandemic Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pandemic Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pandemic Sciences Today - Breaking & Trending Today

Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS) - Vimarsana News

Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched last week (Friday 15 September 2023).This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at t

Preparing for the net pandemic: MERS and the path towards a vaccine - Vimarsana News

Preparing for the net pandemic: MERS and the path towards a vaccine

The World Health Organization (WHO) recognises MERS as a priority infectious disease that requires urgent research to develop vaccines.

Study shows convalescent plasma works for immune-compromised Covid-19 patients, but it can be hard to find - Vimarsana News

Study shows convalescent plasma works for immune-compromised Covid-19 patients, but it can be hard to find

Convalescent plasma -- a once-celebrated treatment for Covid-19 that has largely fallen out of favor -- does work well for people who are immune-compromised, according to a study published Thursday.

Source: wktv.com
Health officials probe Argentina pneumonia cases; three dead - Vimarsana News

Health officials probe Argentina pneumonia cases; three dead

Argentine health authorities are investigating a cluster of pneumonia cases from an unknown cause that has led to three deaths out of nine cases ident...

British scientists behind key COVID trial launch study to test monkeypox treatment - Vimarsana News

British scientists behind key COVID trial launch study to test monkeypox treatment

LONDON— The British scientists behind one of the major therapeutic COVID-19 trials have turned their focus to treatments for monkeypox, a viral disease